Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

By Lagging Martin  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 7, 2013-07 ,pp. : 839-847

Informa Healthcare

Access to resources Recommend Favorite

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

Sustained Virological Response after 8-Week Treatment of Simeprevir with Peginterferon α-2a plus Ribavirin in a Japanese Female with Hepatitis C Virus Genotype 1b and IL28B Minor Genotype

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

By Nishiguchi Shuhei   Enomoto Hirayuki   Aizawa Nobuhiro   Nishikawa Hiroki   Osaki Yukio   Tsuda Yasuhiro   Higuchi Kazuhide   Okazaki Kazuichi   Seki Toshihito   Kim Soo   Hongo Yasushi   Jyomura Hisato   Nishida Naoshi   Kudo Masatoshi  

Journal of Gastroenterology, Vol. 49, Iss. 3, 2014-03 ,pp. : 492-501

Springer Publishing Company

Access to resources Recommend Favorite

Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy

By Graham Camilla S.   Lontok Erik   Mani Nina   Harrington Patrick R.   Miller Veronica  

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1466-1470

Oxford University Press

Access to resources Recommend Favorite